Characteristics of patients
| Characteristics | Group A* (n=89) | Group B† (n=49) | P value |
| Age (years), median (range) | 45 (31–66) | 43 (25–64) | 0.80 |
| ECOG status | |||
| 0 | 72 (80.9%) | 37 (75.5%) | |
| 1 | 15 (16.9%) | 10 (20.4%) | 0.71 |
| 2 | 2 (2.2%) | 2 (4.1%) | |
| Histology | |||
| SCC | 66 (74.2%) | 40 (81.6%) | 0.32 |
| Non-SCC | 23 (25.8%) | 9 (18.4%) | |
| FIGO stage | |||
| IB1, IB2 | 74 (83.1%) | 42 (85.7%) | 0.69 |
| IIA1 | 15 (16.9%) | 7 (14.3%) | |
| Number of positive lymph nodes | |||
| 1 | 39 (43.8%) | 26 (53.1%) | 0.30 |
| ≥2 | 50 (56.2%) | 23 (46.9%) | |
| Lymphovascular space invasion | |||
| Yes | 74 (83.1%) | 35 (71.4%) | 0.11 |
| No | 15 (16.9%) | 14 (28.6%) | |
| Stromal invasion depth | |||
| ≥1/3 | 80 (89.9%) | 39 (79.6%) | 0.09 |
| <1/3 | 9 (10.1%) | 10 (20.4%) | |
| Positive CILN/PALN | |||
| Yes | 14 (15.7%) | 6 (12.2%) | 0.56 |
| No | 75 (84.3%) | 43 (87.8%) |
*Group A: consolidation chemotherapy group.
†Group B: concurrent chemoradiotherapy alone group.
CILN, common iliac lymph node; ECOG, Eastern Cooperative Oncology Group; FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; PALN, para-aortic lymph node; SCC, squamous cell carcinoma.